We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is continuing its battle to stop the illegal importation of prescription drugs from Canada, issuing a warning letter Jan. 22 to a pharmacy benefits manager (PBM), insurance company and claims processor. PBM Expedite-Rx, claims processor SPC Global Technologies and insurer Employer Health Options were accused by the agency of “facilitating illegal imports of [Rx] drugs from Canada and misleading the public about the drugs’ safety.”